Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study (vol 8, 386, 2017)

被引：3

作者：

Queirolo, Paola ^{[1
]}

Dozin, Beatrice ^{[2
]}

Morabito, Anna ^{[3
]}

Banelli, Barbara ^{[3
,4
]}

Piccioli, Patrizia ^{[5
]}

Fava, Cristiana ^{[1
]}

Leo, Claudio ^{[1
]}

Carosio, Roberta ^{[3
]}

Laurent, Stefania ^{[6
,7
]}

Fontana, Vincenzo ^{[2
]}

Ferrucci, Pier Francesco ^{[8
]}

Martinoli, Chiara ^{[8
]}

Cocorocchio, Emilia ^{[8
]}

Battaglia, Angelo ^{[8
]}

Ascierto, Paolo A. ^{[9
]}

Capone, Mariaelena ^{[9
]}

Simeone, Ester ^{[9
]}

De Galitiis, Federica ^{[10
]}

Pagani, Elena ^{[10
]}

Cappellini, Gian Carlo Antonini ^{[10
]}

Marchetti, Paolo ^{[10
,11
]}

Guida, Michele ^{[12
]}

Tommasi, Stefania ^{[12
]}

Mandala, Mario ^{[13
]}

Merelli, Barbara ^{[13
]}

Quaglino, Pietro ^{[14
]}

Fava, Paolo

Guidoboni, Massimo ^{[15
]}

Romani, Massimo ^{[3
]}

Spagnolo, Francesco ^{[1
]}

Pistillo, Maria Pia ^{[3
]}

机构：

[1] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Dept Med Oncol, Genoa, Italy

[2] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Unit Clin Epidemiol, Genoa, Italy

[3] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Unit Tumor Epigenet, Genoa, Italy

[4] Univ Genoa, Dept Hlth Sci, Genoa, Italy

[5] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Unit Cellular Biol, Genoa, Italy

[6] Univ Genoa, IMI, Genoa, Italy

[7] Univ Genoa, Dept Internal Med, Genoa, Italy

[8] European Inst Oncol, Oncol Melanoma Unit, Milan, Italy

[9] Fdn G Pascale, Ist Nazl Tumori, Canc Immunotherapy & Innovat Therapy Unit, Melanoma, Naples, Italy

[10] Ist Dermopat Immacolata IDI IRCCS, Rome, Italy

[11] Sapienza Univ Rome, St Andrea Hosp, Med Oncol, Rome, Italy

[12] IRCCS Ist Tumori Giovanni Paolo II, Dept Med Oncol, Mol Genet Lab, Bari, Italy

[13] Papa Giovanni XXIII Hosp, Dept Hematol & Oncol, Unit Med Oncol, Bergamo, Italy

[14] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy

[15] IRCCS IRST, Immunotherapy & Cell Therapy, Meldola, Italy

来源：

FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷

关键词：

CTLA-4; variants; melanoma; ipilimumab; best overall response; overall survival; predictive/prognostic factor;

D O I：

10.3389/fimmu.2018.00403

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页数：2

共 5 条

[1] Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study
Queirolo, Paola
Dozin, Beatrice
Morabito, Anna
Banelli, Barbara
Piccioli, Patrizia
Fava, Cristiana
Leo, Claudio
Carosio, Roberta
Laurent, Stefania
Fontana, Vincenzo
Ferrucci, Pier Francesco
Martinoli, Chiara
Cocorocchio, Emilia
Battaglia, Angelo
Ascierto, Paolo A.
Capone, Mariaelena
Simeone, Ester
De Galitiis, Federica
Pagani, Elena
Cappellini, Gian Carlo Antonini
Marchetti, Paolo
Guida, Michele
Tommasi, Stefania
Mandala, Mario
Merelli, Barbara
Quaglino, Pietro
Fava, Paolo
Guidoboni, Massimo
Romani, Massimo
Spagnolo, Francesco
Pistillo, Maria Pia
FRONTIERS IN IMMUNOLOGY, 2017, 8
[2] Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Pistillo, Maria Pia
Fontana, Vincenzo
Morabito, Anna
Dozin, Beatrice
Laurent, Stefania
Carosio, Roberta
Banelli, Barbara
Ferrero, Francesca
Spano, Laura
Tanda, Enrica
Ferrucci, Pier Francesco
Martinoli, Chiara
Cocorocchio, Emilia
Guida, Michele
Tommasi, Stefania
De Galitiis, Federica
Pagani, Elena
Cappellini, Gian Carlo Antonini
Marchetti, Paolo
Quaglino, Pietro
Fava, Paolo
Osella-Abate, Simona
Ascierto, Paolo Antonio
Capone, Mariaelena
Simeone, Ester
Romani, Massimo
Spagnolo, Francesco
Queirolo, Paola
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (01) : 97 - 107
[3] Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study
Maria Pia Pistillo
Vincenzo Fontana
Anna Morabito
Beatrice Dozin
Stefania Laurent
Roberta Carosio
Barbara Banelli
Francesca Ferrero
Laura Spano
Enrica Tanda
Pier Francesco Ferrucci
Chiara Martinoli
Emilia Cocorocchio
Michele Guida
Stefania Tommasi
Federica De Galitiis
Elena Pagani
Gian Carlo Antonini Cappellini
Paolo Marchetti
Pietro Quaglino
Paolo Fava
Simona Osella-Abate
Paolo Antonio Ascierto
Mariaelena Capone
Ester Simeone
Massimo Romani
Francesco Spagnolo
Paola Queirolo
Cancer Immunology, Immunotherapy, 2019, 68 : 97 - 107
[4] Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
Queirolo, P.
Morabito, A.
Laurent, S.
Lastraioli, S.
Piccioli, P.
Ascierto, P. A.
Gentilcore, G.
Serra, M.
Marasco, A.
Tornari, E.
Dozin, B.
Pistillo, M. P.
CANCER INVESTIGATION, 2013, 31 (05) : 336 - 345
[5] Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
Bajor, David L.
Mick, Rosemarie
Riese, Matthew J.
Huang, Alex C.
Sullivan, Brendan
Richman, Lee P.
Torigian, Drew A.
George, Sangeeth M.
Stelekati, Erietta
Chen, Fang
Melenhorst, J. Joseph
Lacey, Simon F.
Xu, Xiaowei
Wherry, E. John
Gangadhar, Tara C.
Amaravadi, Ravi K.
Schuchter, Lynn M.
Vonderheide, Robert H.
ONCOIMMUNOLOGY, 2018, 7 (10):

← 1 →